Bausch + Lomb and AcuFocus, a privately held ophthalmic medical device company, announced that an affiliate of Bausch + Lomb has acquired AcuFocus, pursuant to a merger transaction with the parent company of AcuFocus.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on BLCO:
- Bausch + Lomb Novaliq announce GOBI trial met both co-primary endpoints
- Bausch + Lomb amends CEO separation agreement
- Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
- Bausch + Lomb initiated with an Equal Weight at Barclays
- Bausch + Lomb’s Biotrue contact lense cleaner receives 510(k) clearance from FDA